CONTACT-02: limited clinical benefit and a suboptimal control group - Authors' reply.
Saved in:
| Title: | CONTACT-02: limited clinical benefit and a suboptimal control group - Authors' reply. |
|---|---|
| Authors: | Agarwal N; Department of Internal Medicine, Division of Medical Oncology, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA. Electronic address: neeraj.agarwal@hci.utah.edu., Merseburger AS; Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany., Andrianova S; Exelixis, Alameda, CA, USA., Azad AA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2025 Oct; Vol. 26 (10), pp. e512-e513. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-5488 |
|---|---|
| DOI: | 10.1016/S1470-2045(25)00538-8 |
